PVSRIPO in Combination With Nivolumab in Melanoma
Condition: Melanoma Interventions: Biological: PVSRIPO; Drug: Nivolumab Sponsors: Darell D. Bigner, MD, PhD; Duke University; Istari Oncology, Inc.; Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials